Equibles does not estimate personal net worth.
Get an email with a short summary when Agios Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AGIO alertsDr. Kenneth Ataga has spoken on 1 investor event across 1 company, most recently for Agios Pharmaceuticals, Inc. on June 13, 2026. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Agios Pharmaceuticals, Inc. includes Brian Goff (CEO and Board Member), Jacqualyn Fouse (CEO and Board Member), David P. Schenkein (Chairman) and 7 others.
“So the one thing I would add to what Aron has said is the fact that Sickle cells, this is very heterogeneous, right? So within patients and between patients, they can have varying similarities of disease at certain times, at different times.”
Transcript header (unverified)
Biotechnology · Healthcare
